Clinical Trial Update: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

View source ↗

Summary

A completed clinical trial update for an infant study of the Meningococcal Quadrivalent CRM-197 Conjugate Vaccine, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal Quadrivalent CRM-197 Conjugate Vaccine (CRM-197 conjugate meningococcal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Meningococcal Disease, Infections, Meningococcal | Status: COMPLETED | Results posted: 2019-10-21